Silva Pharmaceuticals
Silva Pharmaceuticals Limited is a Dhaka-based pharmaceutical manufacturer producing 187+ generic medicines across 350+ presentations in 9 therapeutic categories, serving healthcare providers and patients in Bangladesh via a sales-led distribution model across Pharmaceuticals, AgroVet, and Herbal & Nutraceuticals segments.
- Company typePublic
- Founded2003
- HeadquartersDhaka, Bangladesh
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Silva Pharmaceuticals does
Silva Pharmaceuticals Limited is a Bangladesh-based pharmaceutical manufacturer and marketer founded in 2003 and headquartered in Dhanmondi, Dhaka. The company manufactures and sells finished pharmaceutical products across nine therapeutic categories — Anti-Infective, Gastro-Intestinal System, Cardiovascular System, Respiratory System, Endocrine System, Central Nervous System, Musculoskeletal & Joint Disease, Anemia & Other Blood Disorders, and Nutrition & Disinfectants — through a portfolio of more than 187 generic medicines available in over 350 different presentations. Silva's product portfolio is organized into three segments: Pharmaceuticals (branded generics), AgroVet & Pesticides, and Herbal & Nutraceuticals. The company operates a modern pharmaceutical plant equipped with advanced manufacturing machinery and a domestic distribution network reaching healthcare providers and patients across Bangladesh.
The company has been publicly traded on the Dhaka Stock Exchange (DSE) and Chittagong Stock Exchange (CSE) under the ticker SILVAPHL since October 10, 2018, following BSEC consent in July 2018. Its go-to-market is sales-led, relying on traditional pharmaceutical distribution channels in Bangladesh with field-level engagement of healthcare providers; the firmographic record explicitly indicates products are sold mainly in the local market. Headcount is reported in the 1,001–5,000 range. The website maintains an investor relations section publishing annual, half-yearly, and quarterly reports, indicating ongoing public-company disclosure obligations. No direct revenue figure, customer logos, named partnerships, or M&A activity was disclosed in the source materials, and the financial table provided contains figures whose currency and scale are ambiguous.
Silva Pharmaceuticals firmographics
Firmographics- Name
- Silva Pharmaceuticals
- Legal name
- Silva Pharmaceuticals Ltd.
- Website
- https://silvapharma.com
- Company type
- Public
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Silva Pharmaceuticals Limited is a Dhaka-based pharmaceutical manufacturer producing 187+ generic medicines across 350+ presentations in 9 therapeutic categories, serving healthcare providers and patients in Bangladesh via a sales-led distribution model across Pharmaceuticals, AgroVet, and Herbal & Nutraceuticals segments.
- Ownership category
- akta.pro rank
Silva Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Silva Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Dhaka
- HQ country
- Bangladesh
- HQ region
- Asia
Offices1 record
Markets served
Silva Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Product Sales: The company generates revenue through manufacturing and marketing of pharmaceutical finished products. Silva Pharmaceuticals produces more than 187 generic medicines available in over 350 different presentations, covering all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal products. Revenue is derived from domestic sales in Bangladesh as well as broad international markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Silva Pharmaceuticals product offering
Product offeringCore offering
Silva Pharmaceuticals Limited manufactures and markets finished pharmaceutical products in Bangladesh. It produces more than 187 generic medicines available in over 350 presentations covering nine therapeutic categories (Anti-Infective, Gastro-Intestinal System, Cardiovascular System, Respiratory System, Endocrine System, Central Nervous System, Musculoskeletal & Joint Disease, Anemia & Other Blood Disorders, and Nutrition & Disinfectants), with additional offerings in AgroVet & Pesticides and Herbal & Nutraceuticals. Manufacturing is performed at a modern pharmaceutical plant equipped with advanced machinery and technology, with products sold mainly in the local Bangladesh market.
Product overview
Silva Pharmaceuticals Limited operates as a pharmaceutical company engaged in manufacturing and marketing finished pharmaceutical products in Bangladesh. The company maintains a diverse portfolio of more than 187 generic medicines across over 350 presentations, spanning multiple therapeutic categories including Anti-Infective, Gastro-Intestinal System, Cardiovascular System, Respiratory System, Endocrine System, Central Nervous System, Musculoskeletal & Joint Disease, Anemia & Other Blood Disorders, Nutrition & Disinfectants. The product portfolio is organized across three main segments: Pharmaceuticals (branded generic medicines), AgroVet & Pesticides, and Herbal & Nutraceuticals. The company also offers a modern pharmaceutical plant with advanced manufacturing capabilities and operates a distribution network across Bangladesh.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceuticals Portfolio A portfolio of more than 187 generic medicines available in over 350 different presentations, covering all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal products. Sold mainly in the local Bangladesh market to healthcare providers and patients.
- AgroVet & Pesticides Agricultural veterinary products and pesticides product line offered by Silva Pharmaceuticals as a separate segment of its portfolio, addressing agricultural and animal-health applications.
- Herbal & Nutraceuticals Herbal medicines and nutraceuticals product line offered by Silva Pharmaceuticals as part of its broader healthcare portfolio, positioned around natural medication offerings in Bangladesh.
Companies that use Silva Pharmaceuticals
Customer profileSegments1 record
Ideal customer profiles2 records
Silva Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Silva Pharmaceuticals partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights4 records
Silva Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Renata Limited: Bangladesh-based pharmaceutical company with diversified generics and animal health products, listed on the DSE. Directly comparable business model and product breadth to Silva.
- Aristopharma Limited: Bangladesh-based pharmaceutical manufacturer producing generics across multiple therapeutic categories. Directly competes with Silva in the local generics market.
- ACI Limited: Bangladesh conglomerate with a sizable pharmaceuticals division covering generics, consumer health, and animal health. Comparable on multi-segment health product structure.
- Beximco Pharmaceuticals: Leading Bangladesh generic manufacturer with comparable therapeutic-area coverage and significant export footprint. Direct competitor for Silva in domestic generics and a benchmark for export-led growth strategies.
- Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer, producing a broad generic and specialty portfolio across similar therapeutic categories as Silva. Closest direct comparable on product breadth, domestic market focus, and public listing.
- Incepta Pharmaceuticals: Major Bangladesh generic manufacturer with a broad therapeutic portfolio and modern manufacturing. Direct competitor across most of Silva's categories.
- Eskayef Pharmaceuticals: Bangladesh generic manufacturer with broad therapeutic coverage and growing export presence. Direct peer in domestic generics and emerging international markets.
- Drug International Limited: Bangladesh-based pharmaceutical company producing finished generics in multiple dosage forms. Direct competitor for Silva's portfolio of generic finished products.
- Healthcare Pharmaceuticals: Bangladesh generic pharmaceutical manufacturer with a similar broad-portfolio strategy across therapeutic areas. Comparable in scale and market positioning to Silva.
- Globe Pharmaceuticals: Bangladesh generic manufacturer with a broad domestic portfolio. Direct peer competing for the same healthcare-provider and patient customer base as Silva.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Silva Pharmaceuticals social profiles
Digital presenceSilva Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Silva Pharmaceuticals leadership team
Management profileNumber of profiles
Silva Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Silva Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Silva Pharmaceuticals
What does Silva Pharmaceuticals do?
Silva Pharmaceuticals Limited manufactures and markets finished pharmaceutical products in Bangladesh. It produces more than 187 generic medicines available in over 350 presentations covering nine therapeutic categories (Anti-Infective, Gastro-Intestinal System, Cardiovascular System, Respiratory System, Endocrine System, Central Nervous System, Musculoskeletal & Joint Disease, Anemia & Other Blood Disorders, and Nutrition & Disinfectants), with additional offerings in AgroVet & Pesticides and Herbal & Nutraceuticals. Manufacturing is performed at a modern pharmaceutical plant equipped with advanced machinery and technology, with products sold mainly in the local Bangladesh market.
Is Silva Pharmaceuticals a public or private company?
Silva Pharmaceuticals is a public company. It is classified as public and is currently operating.
When was Silva Pharmaceuticals founded?
Silva Pharmaceuticals was founded in 2003. It employs 1,001 to 5,000 people.
Where is Silva Pharmaceuticals based?
Silva Pharmaceuticals is headquartered in Dhaka, Bangladesh, in the Asia region.
How does Silva Pharmaceuticals make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Silva Pharmaceuticals's main competitors?
Direct peers on record are Renata Limited, Aristopharma Limited, ACI Limited, Beximco Pharmaceuticals, Square Pharmaceuticals, Incepta Pharmaceuticals, Eskayef Pharmaceuticals, Drug International Limited, Healthcare Pharmaceuticals and Globe Pharmaceuticals.
Does Silva Pharmaceuticals have an API?
No public API is recorded for Silva Pharmaceuticals.
What industry is Silva Pharmaceuticals in?
Silva Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.